[Federal Register Volume 77, Number 31 (Wednesday, February 15, 2012)]
[Notices]
[Pages 8886-8887]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-3553]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2012-N-0001]
Food and Drug Administration Clinical Trial Requirements,
Regulations, Compliance, and Good Clinical Practice
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public workshop.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) Detroit District
Office, in co-sponsorship with the Society of Clinical Research
Associates (SoCRA) is announcing a public workshop. The public workshop
on FDA's clinical trial requirements is designed to aid the clinical
research professional's understanding of the mission, responsibilities,
and authority of FDA and to facilitate interaction with FDA
representatives. The program will focus on the relationships among FDA
and clinical trial staff, investigators, and institutional review
boards (IRB). Individual FDA representatives will discuss the informed
consent process and informed consent documents; regulations relating to
drugs, devices, and biologics; as well as inspections of clinical
investigators, IRB, and research sponsors.
Date and Time: The public workshop will be held on May 9 and 10,
2012, from 8 a.m. to 5 p.m.
[[Page 8887]]
Location: The public workshop will be held at the Marriott Ann
Arbor Ypsilanti at Eagle Crest, 1275 S. Huron St., Ypsilanti, MI 48197,
800-606-7044.
Contact: Society of Clinical Research Associates (SoCRA), 530 West
Butler Ave., Suite 109, Chalfont, PA 18914, 1-800-762-7292 or 215-822-
8644, FAX: 215-822-8633, email: [email protected], Web site: http://www.SoCRA.org. (FDA has verified the Web site addresses throughout this
document, but we are not responsible for any subsequent changes to the
Web sites after this document publishes in the Federal Register.); or
Nancy Bellamy, Food and Drug Administration, Detroit District Office,
300 River Pl., Suite 5900, Detroit, MI 48207, 313-393-8143, Fax: 313-
393-8139, email: [email protected].
Accommodations: Attendees are responsible for their own
accommodations. Please mention SoCRA to receive the hotel room rate of
$119 plus applicable taxes (available until April 17, 2012 or until the
SoCRA room block is filled).
Cost of Registration
------------------------------------------------------------------------
------------------------------------------------------------------------
SoCRA member............................................... $575
SoCRA nonmember (includes membership)...................... 650
Federal Government member.................................. 450
Federal Government nonmember............................... 525
FDA Employee............................................... *
------------------------------------------------------------------------
* (Free) Fee Waived.
If you need special accommodations due to a disability, please
contact SoCRA (see Contact) at least 21 days in advance. Extended
periods of question and answer and discussion have been included in the
program schedule. SoCRA designates this educational activity for a
maximum of 13.3 Continuing Education Credits for SoCRA CE and Nurse
CNE. SoCRA designates this live activity for a maximum of 13.3 AMA PRA
Category 1 Credit(s) TM. Physicians should claim only the
credit commensurate with the extent of their participation. CME for
Physicians: SoCRA is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing medical education
for physicians. CNE for Nurses: SoCRA is an approved provider of
continuing nursing education by the Pennsylvania State Nurses
Association (PSNA), an accredited approver by the American Nurses
Credentialing Center's Commission on Accreditation (ANCC). ANCC/PSNA
Provider Reference Number: 205-3-A-09.
Registration Instructions: To register, please submit a
registration form with your name, affiliation, mailing address,
telephone, fax number, and email, along with a check or money order
payable to ``SoCRA''. Mail to: SoCRA (see Contact for address). To
register via the Internet, go to http://www.socra.org/html/FDA_Conference.htm. Payment by major credit card is accepted (Visa/
MasterCard/AMEX only). For more information on the meeting
registration, or for questions on the workshop, contact SoCRA (see
Contact).
SUPPLEMENTARY INFORMATION: The public workshop helps fulfill the
Department of Health and Human Services' and FDA's important mission to
protect the public health. The workshop will provide those engaged in
FDA-regulated (human) clinical trials with information on a number of
topics concerning FDA requirements related to informed consent,
clinical investigation requirements, IRB inspections, electronic record
requirements, and investigator initiated research. Topics for
discussion include the following: (1) What FDA Expects in a
Pharmaceutical Clinical Trial; (2) Adverse Event Reporting--Science,
Regulation, Error, and Safety; (3) Part 11 Compliance--Electronic
Signatures; (4) Informed Consent Regulations; (5) IRB Regulations and
FDA Inspections; (6) Keeping Informed and Working Together; (7) FDA
Conduct of Clinical Investigator Inspections; (8) Meetings With FDA:
Why, When, and How; (9) Investigator Initiated Research; (10) Medical
Device Aspects of Clinical Research; (11) Working With FDA's Center for
Biologics Evaluation and Research; (12) The Inspection is Over--What
Happens Next? Possible FDA Compliance Actions; (13) Ethical Issues in
Subject Enrollment; (14) Medical Device Aspects of Clinical Research;
(15) Are We There Yet? An Overview of the FDA GCP Program.
FDA has made education of the drug and device manufacturing
community a high priority to help ensure the quality of FDA-regulated
drugs and devices. The public workshop helps to achieve objectives set
forth in section 406 of the FDA Modernization Act of 1997 (21 U.S.C.
393) which includes working closely with stakeholders and maximizing
the availability and clarity of information to stakeholders and the
public. The public workshop also is consistent with the Small Business
Regulatory Enforcement Fairness Act of 1996 (Pub. L. 104-121) as
outreach activities by Government Agencies to small businesses.
Dated: February 9, 2012.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2012-3553 Filed 2-14-12; 8:45 am]
BILLING CODE 4160-01-P